The CD44v6 isoform forms a trimeric complex with MET and hepatocyte growth factor, activating RAS-MAPK, PI3K/Akt, and MET transcription pathways, contributing to chemoresistance and tumor progression [123]. The gene discussed is MET; the disease is neoplasm.